In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Dallas and Phoenix labs. The ability to test healthcare partner samples at any one of the three labs is a critical element in creating the reliability the CTS healthcare partners desire so they can provide the blood that saves patients’ lives.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...